{"nct_id":"NCT02335411","title":"A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)","status":"COMPLETED","status_verified_date":"2022-07","start_date":"2015-02-03","start_date_type":"ACTUAL","primary_completion_date":"2021-07-23","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}